Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0A5ZJ
|
||||
Former ID |
DIB008755
|
||||
Drug Name |
DW-1350
|
||||
Synonyms |
DW-1352; Osteoblast modulator (oral, osteoporosis), Dong Wha/ Teijin/ Procter & Gamble
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Osteoporosis [ICD9: 733.0, V07.4; ICD10:M80-M81, Z79.890] | Terminated | [548554] | ||
Company |
Dong Wha Pharmaceutical Co Ltd
|
||||
Structure |
Download2D MOL |
||||
Formula |
C25H31N3O3S
|
||||
Canonical SMILES |
c1(sc(nc1c1ccc(OCCCCCOc2ccc(cc2)/C(=N\O)/N)cc1)C)C(C)C
|
||||
CAS Number |
CAS 491577-61-8
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Leukotriene B4 receptor 1 | Target Info | Modulator | [548594] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
NetPath Pathway | IL4 Signaling Pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.